Graf Akcie ALXN (Alexion Pharmaceuticals Inc.). Diskuze k akciím ALXN. Aktuální informace ALXN.

Základní informace o společnosti Alexion Pharmaceuticals Inc. (Akcie ALXN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 40.34B
Hodnota podniku (EV) N/A
Tržby 6.262B
EBITDA 3.18B
Zisk 681.8M
Růst v tržbách Q/Q 13.27 %
Růst v tržbách Y/Y 18.24 %
P/E (Cena vůči ziskům) 58.49
Forward P/E N/A
EV/Sales 6.32
EV/EBITDA N/A
EV/EBIT 51.25
PEG 1.17
Price/Sales 6.47
P/FCF 13.55
Price/Book 3.46
Účetní hodnota na akcii 52.72
Hotovost na akcii 13.57
FCF vůči ceně 7.38 %
Počet zaměstnanců 2,525
Tržba na zaměstnance 2480000
Profit margin 9.94 %
Operating margin 47.41 %
Gross margin 90.88 %
EBIT margin 12.15 %
EBITDA margin 50.79 %
EPS - Zisk na akcii 3.12
EPS - Kvartální růst 9.32 %
EPS - Očekávaný růst příští rok 7.07 %
Return on assets 10.08 %
Return on equity 4.43 %
ROIC 3.78 %
ROCE 4.42 %
Dluhy/Equity 0.55
Čistý dluh/EBITDA -0.25
Current ratio 4.52
Quick Ratio 3.47
Volatilita 1.17
Beta 0.00
RSI 52.18
Cílová cena analytiků 146
Známka akcie (dle analytiků) 1.92
Insider ownership 0.34 %
Institutional ownership 88.27 %
Počet akcií 221.019M
Procento shortovaných akcií 3.84 %
Short ratio 4.24 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1996
Země United States

Finanční výsledky akcie ALXN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$6,069.9$4,991.1$4,131.2$3,551.1$3,084.1$2,604
Cost Of Goods Sold$553.5$394.5$374.3$454.2$258.3$233.1
Gross Profit$5,516.4$4,596.6$3,756.9$3,096.9$2,825.8$2,370.9
Research And Development Expenses$1,002.9$886$730.4$878.4$757.2$709.5
SG&A Expenses$1,399.9$1,261.1$1,111.8$1,094.4$953$862.6
Other Operating Income Or Expenses$-2,099.7$-11.6$-116.5$-72$-120.7$-64.2
Operating Expenses$5,437.6$2,870.7$3,861.6$2,923.7$2,416.7$2,067.3
Operating Income$632.3$2,120.4$269.6$627.4$667.4$536.7
Total Non-Operating Income/Expense$-63.3$58.4$-27.4$-79.6$-91.2$-38.6
Pre-Tax Income$569$2,178.8$242.2$547.8$576.2$498.1
Income Taxes$-34.4$-225.5$164.6$104.5$176.8$353.7
Income After Taxes$603.4$2,404.3$77.6$443.3$399.4$144.4
Other Income------
Income From Continuous Operations$603.4$2,404.3$77.6$443.3$399.4$144.4
Income From Discontinued Operations------
Net Income$603.4$2,404.3$77.6$443.3$399.4$144.4
EBITDA$3,015$2,497.2$688.4$1,124.1$1,063.8$703.3
EBIT$632.3$2,120.4$269.6$627.4$667.4$536.7
Basic Shares Outstanding220223223224224213
Shares Outstanding222225225225226216
Basic EPS$2.74$10.77$0.35$1.98$1.78$0.68
EPS - Earnings Per Share$2.72$10.70$0.35$1.97$1.76$0.67
# 2020 2019 2018 2017 2016 2015
Current Ratio3.59024.25052.88333.10123.13313.4076
Long-term Debt / Capital0.1720.1740.2380.25620.26420.2919
Debt/Equity Ratio0.21990.22190.34990.36330.37830.4392
Gross Margin90.881292.095990.939787.209691.624891.0484
Operating Margin10.41742.48366.52617.667821.6420.6106
EBIT Margin10.41742.48366.52617.667821.6420.6106
EBITDA Margin49.671350.033116.663431.65534.493127.0085
Pre-Tax Profit Margin9.374143.65375.862715.426218.682919.1283
Net Profit Margin9.940948.17181.878412.483512.95035.5453
Asset Turnover0.33530.28450.29650.26140.23270.1988
Inventory Turnover Ratio0.71350.62860.79220.98650.68940.8038
Receiveable Turnover4.3074.01474.47924.8884.74774.8856
Days Sales In Receivables84.745190.915481.487174.673376.879574.7101
ROE - Return On Equity5.178921.33020.84674.98484.59411.7484
Return On Tangible Equity17.003483.190915.9474-449.1379-61.7597-9.646
ROA - Return On Assets3.333113.70390.5573.26363.01361.1025
ROI - Return On Investment4.288317.61810.64523.70753.38041.238
Book Value Per Share53.080650.934541.008140.00538.828936.7067
Operating Cash Flow Per Share4.25217.3769-3.05180.14911.6729-0.0409
Free Cash Flow Per Share4.45977.6375-2.41540.03411.5288-0.6888